首页>
外国专利>
Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD
Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD
展开▼
机译:在被诊断患有FXS和ASD的个体中调节sAPP,sAPP alpha和BDNF水平
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate.
展开▼